Free Trial

Curaleaf (OTCMKTS:CURLF) Shares Gap Down - What's Next?

Curaleaf logo with Medical background

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $1.24, but opened at $1.20. Curaleaf shares last traded at $1.21, with a volume of 333,782 shares trading hands.

Curaleaf Price Performance

The firm has a market cap of $835.38 million, a price-to-earnings ratio of -4.02 and a beta of 0.62. The company has a debt-to-equity ratio of 1.08, a quick ratio of 0.70 and a current ratio of 1.41. The business has a 50 day simple moving average of $0.89 and a 200-day simple moving average of $1.05.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.07). Curaleaf had a negative return on equity of 14.12% and a negative net margin of 17.37%. Equities research analysts expect that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Recommended Stories

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines